Patent foramen ovale and migraine: Where is the connection?;Foramen oval permeable y migraña: ¿Idónde está la conexión?

Neurologia

Volumn 23, Issue 8, 2008, Pages 475-483

  Cuadrado, María Luz ^a   Pareja, J A ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Migraine; Migraine with aura; Patent foramen ovale; Right to left shunt; Treatment

Indexed keywords

ARTERIOVENOUS SHUNT; EMBOLISM; HUMAN; MIGRAINE; MIGRAINE AURA; OBSERVATIONAL STUDY; PATENT FORAMEN OVALE; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

FORAMEN OVALE, PATENT; HUMANS; MIGRAINE WITH AURA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 55849146281     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
2. Sacco RL, Homma S, Di Tullio MR. Patent foramen ovale: a new risk factor for ischemic stroke. Heart Dis Stroke 1993;2:235-41.
3. Serena J. Foramen oval permeable: ¿cómo y de qué es factor de riesgo? Neurología 2006;21:689-94.
4. Ries S, Steinke W, Neff W, Schindlmayr C, Meairs S, Hennerici M. Ischemia-induced migraine from paradoxical cardioembolic stroke. Eur Neurol 1996;36:76-8.
5. Brennigstall GN. An adolescent with complicated migraine. Semin Pediatr Neurol 1999;6:173-5.
6. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001;100:215-20.
7. Diener HC, Weimar C, Katsarava Z. Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol 2005;18:299-304.
8. Piechowski-Jozwiak B, Devuyst G, Bogousslavsky J. Migraine and patent foramen ovale: a residual coincidence or a pathophysiological intrigue? Cerebrovasc Dis 2006;22:91-100.
9. Adler E, Love B, Giovannone S, Volpicelli F, Goldman ME. Correlation or causation: untangling the relationship between patent foramen ovale and migraine. Curr Cardiol Rep 2007;9:7-12
10. Anzola GP. Patent foramen ovale and migraine. Cleve Clin J Med 2007;74(Suppl. 1):S114-7.
11. Diener HC, Kurth T, Dodick D. Patent foramen ovale and migraine. Curr Pain Headache Rep 2007;11:236-40.
12. Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 2007;20: 310-9.
13. Diener HC on behalf of the Council of the European Headache Federation. Patent foramen ovale: no reason to intervene. J Headache Pain 2007;8:3-6.
14. Tepper SJ, Sheftell FD, Bigal ME. The patent foramen ovale-migraine question. Neurol Sci 2007;28:S118-23.
15. Spies C, Kavinsky CJ, Schräder R. Patent foramen ovale in patients with migraine headache. Should it be closed? Minerva Med 2007;98:25-36.
16. a ed. Madrid: Elsevier, 2003.
17. a ed. Madrid: Elsevier, 2005.
18. a ed. Buenos Aires: Ed. Médica Panamericana, 2007.
19. Thompson T, Evans W. Paradoxical embolism. Q J Med 1930;23:135-52.
20. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
21. Penther P. Le foramen ovale permeable: étude anatomique, à propos de 500 autopsies consécutives. Arch Mal Coeur Vaiss 1994;87:15-21.
22. Fisher DC, Fisher EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1,000 consecutive patients. A contrast transesophageal echocardiography study. Chest 1995; 107:1504-9.
23. Meissner I, Whisnant JP, Khanderia BK, Spittell PC, O'Fallon WM, Pascoe RD et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: assessment of Risk in a Community. Mayo Clin Proc 1999;74:862-9.
24. Cerrato P, Imperiale D, Priano K, Mangiardi L, Morello M, Marson AM, et al. Transoesophageal echocardiography in patients without arterial and major cardiac sources of embolism: difference between stroke subtypes. Cerebrovasc Dis 2002;13:174-83.
25. Serafini O, Misuraca G, Greco F, Bisignani G, Manes MT, Venneri N. Prevalenza di anomalie del setto interatriale e loro associazione con recenti episodi di stroke/attacco isehemico transitorio: volutazione ecoeardiografica in 18631 pazienti. Ital Heart J Suppl 2003;4:39-45.
26. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005;65:1415-8.
27. Molins A, Serena J, Genis D, Bassaganyas J, Pérez-Ayuso MJ, Dávalos A. Utilidad del Doppler transcraneal con contraste para el diagnóstico de la comunicación derecha-izquierda en el infarto cerebral de adultos jóvenes. Neurología 1996;11:205-9.
28. Droste DW, Schmidt-Rimpler C, Wichter T, Dittrich R, Ritter M, Stypmann J, et al. Right-to-left shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis 2004;17:191-6.
29. Klötzsch C, Sliwka U, Berlit P, Noth J. An increased frequency of patent foramen ovale in patients with transient global amnesia. Analysis of 53 consecutive patients. Arch Neurol 1996;53:504-8.
30. Moon RE, Camporesi EM, Kisslo JA. Patent foramen ovale and decompression sickness in divers. Lancet 1989;1:513-4.
31. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998;8:327-30.
32. Anzola GP, Magoni MD, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura. A transcranial Doppler study. Neurology 1999;52:1622-5.
33. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia 2008;28:531-40.
34. Ferrarini G, Malferrari G, Zucco R, Gaddi O, Norina M, Pini LA. High prevalence of patent foramen ovale in migraine with aura. J Headache Pain 2005;6:71-6.
35. Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005;6:328-30.
36. Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 2006;26: 934-9.
37. Tembl J, Lago A, Sevilla T, Solis P, Vilchez J. Migraine, patent foramen ovale and migraine triggers. J Headache Pain 2007;8:7-12.
38. Domitrz I, Mieszkowski J, Kaminska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache 2007;47:1311-8.
39. Tembl-Ferrairó JI, Lago-Martín A, Sevilla T, Boscá-Blasco I, Fages EM, Vilchez-Padilla JJ. Migraña con aura, shunt derecha-izquierda y frecuencia de crisis. Rev Neurol 2007;45:144-6.
40. Anzola GP, Meneghetti G, Zanferrari C, Adami A, Dinia K, Del Sette M. Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia 2008; 28:360-6.
41. Del Sette M, Dinia L, Bonzano L, Roccatagliata L, Finocchi C, Parodi RC, et al. White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia 2008;28:376-82.
42. Boscá-Blasco ME, Tembl-Ferrairó JI, Boscá-Blasco I, Lago-Martin A. Estudio de la relación entre lesiones de sustancia blanca en la resonancia magnética y foramen oval permeable en pacientes con migrarĩa. Neurología 2008;23:499-502.
43. Ramírez-Moreno JM, Casado-Naranjo I, Gómez M, Portilla JC, Caballero M, Serrano A, et al. Migraña con aura y foramen oval permeable. ¿Una entidad clínica diferente? Neurología 2008;23:503-10.
44. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 2006;66:765-7.
45. Jesurum JT, Fuller CJ, Velez CA, Spencer MP, Krabill KA, Likosky WH, et al. Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics. J Headache Pain 2007;8:209-16.
46. Scher AI, Stewart WF, Lipton RB. Migraine and headache: a meta-analytic approach. En: Crombie IK, editor. Epidemiology of Pain. Seattle: IASP Press, 1999; p. 159-70.
47. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002;13:102-6.
48. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003;16:39-42.
49. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439-40.
50. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62:1399-401.
51. Wilmshurst P, Pearson M, Nightingale S. Re-evaluation of the relationship between migraine and persistent foramen ovale and other right-to-left shunts. Clin Sci (Lond) 2005;108:365-7.
52. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45: 493-5.
53. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006;37:430-4.
54. Wilmshurst P, Nightingale S, Pearson M, Morrison L, Walsh K. Relation of atrial shunts to migraine in patients with ischemic stroke and peripheral emboli. Am J Cardiol 2006;98:831-3.
55. Kimmelstiel C, Gange C, Thaler D. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc Interv 2007;69:740-6.
56. Carod-Artal FJ, Vilela-Nunes S, Portugal D. Trombofilia y foramen oval permeable en pacientes jóvenes afectos de ictus isquémico. Neurología 2006;21:710-6.
57. Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache 2006;46:429-34.
58. Gori S, Morelli N, Fanucchi S, Gallerini S, Manca ML, Orlandi G, et al. The extent of right-to-left shunt fails to correlate with severity of clinical picture in migraine with aura. Neurol Sci 2006; 27:14-7.
59. Dinia L, Roccatagliata L, Bonzano L, Finocchi C, Del Sette M. Diffusion MRI during migraine with aura attack associated with diagnostic microbubbles injection in subjects with large PFO. Headache 2007;47:1455-6.
60. Arquizan C, Coste J, Touboul PJ, Mas JL. Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke 2001;32:1563-6.
61. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90:1315-20.
62. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-8.
63. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-51.
64. Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, et al. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia. Catheter Cardiovasc Interv 2007;70:429-33.
65. Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Liebeskind DS. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007;99:1316-20.
66. Dubiel M, Bruch L, Schmehl I, Liebner M, Winkelmann A, Stretz A, et al. Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol 2008;21:32-7.
67. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention With STARFlex Technology (MIST) Trial. A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-404.
68. Yankovsky A, Kuritzky A. Transformation into daily migraine with aura following transcutaneous atrial septal defect closure. Headache 2003;43:496-8.
69. Riederer F, Kaya M, Plank C, Gabriel H, Wessely P. Migraine with aura related to closure of atrial septal defects. Headache 2005;44:953-6.
70. Rodés-Cabau J, Mineau S, Marrero A, Houde C, Mackey A, Côté JM, et al. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defector patent foramen ovale. Am J Cardiol 2008;101:88-92.
71. Caroll JD. Migraine Intervention With STARFlex Technology Trial. A controversial trial of migraine and patent foramen ovale closure. Circulation 2008;117:1358-60.